CVS Health Corporation (NYSE:CVS) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of CVS Health Corporation (NYSE:CVS) have received a consensus recommendation of “Moderate Buy” from the twenty-four research firms that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and twenty-two have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $107.1667.

Several research firms have commented on CVS. Wells Fargo & Company lifted their price target on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Sanford C. Bernstein raised their target price on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. JPMorgan Chase & Co. boosted their target price on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Truist Financial upped their price target on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th.

Institutional Investors Weigh In On CVS Health

A number of institutional investors have recently added to or reduced their stakes in CVS. BlackRock Inc. acquired a new stake in CVS Health during the 2nd quarter worth approximately $12,747,462,000. Norges Bank purchased a new stake in CVS Health during the fourth quarter worth approximately $1,666,265,000. Bank of America Corp DE increased its position in shares of CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after acquiring an additional 13,836,701 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of CVS Health by 193.2% in the 4th quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after acquiring an additional 12,233,675 shares during the period. Finally, Pzena Investment Management LLC acquired a new position in shares of CVS Health during the 2nd quarter valued at $1,217,558,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS stock opened at $93.01 on Monday. The stock has a market capitalization of $118.96 billion, a price-to-earnings ratio of 24.61, a price-to-earnings-growth ratio of 0.85 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health has a 52-week low of $69.51 and a 52-week high of $110.68. The stock’s fifty day simple moving average is $102.02 and its 200-day simple moving average is $88.95.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same period in the prior year, the firm posted $1.81 earnings per share. The business’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts expect that CVS Health will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.